Skip to main content

Advertisement

Log in

Association of interleukin-10 (A1082G) gene polymorphism with oral squamous cell carcinoma in north Indian population

  • RESEARCH ARTICLE
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

The functional polymorphism A1082G in the gene (IL10) for interleukin-10 associated with risk of oral squamous cell carcinoma (OSCC). The present case–control study was to evaluate the possible association between IL10 A1082G gene and OSCC in north Indian population. Analysis of IL10 A1082G genotype in 232 OSCC cases and 221 healthy controls of comparable age, gender, smokers, tobacco chewing and alcohol consumption. IL10 A1082G status in cases and controls were evaluated by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). The frequencies of IL10 A1082G polymorphism AA, AG, GG genotypes were 29.74, 68.10 and 2.15% in OSCC cases and 57.46, 42.08 and 0.45% in healthy controls. The average frequency of G mutant allele was 36.20% in OSCC cases compared with 21.50% among the controls and this allele was associated with increased risk for OSCC cases. Heterozygous AG genotype was found statistically significant in OSCC cases than in controls (OR = 1.6, 95% CI = 1.1–2.2, P = 0.003), whereas homozygous mutant GG genotype was not found significant (OR = 4.7, 95% CI = 0.55–41.1, P = 0.2). Moreover, we found that G allele was significant in OSCC cases of tobacco chewing. The frequency of IL10 A1082G polymorphism G allele and AG genotype is associated with OSCC cases as compared with controls; this may be due to smoking and tobacco chewing. Our findings showed that in IL10 A1082G gene polymorphism AG genotype and G allele may participate in the progression of OSCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  • Cantagrel A., Navaux F., Loubet-Lescoulie P., Nourhashemi F., Enault G., Abbal M. et al. 1999 Interleukin-1 beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 42, 1093–1100.

    Article  CAS  PubMed  Google Scholar 

  • Chand-Bhayal A., Krishnaveni D., Pandu Ranga Rao K., Prabhakar B., Vidyasagar A., Murali Krishna B. et al. 2012 Association of interleukin-10 promoter polymorphism (–1082 G/A) and gastric cancer in Andhra Pradesh population of south India. Iran J. Cancer Prev. 3, 117–123.

    Google Scholar 

  • Chatterjee R., Batra J., Kumar A., Mabalirajan U., Nahid S., Niphadkar P. V. and Ghosh B. 2005 Interleukin-10 promoter polymorphisms and atopic asthma in north Indians. Clin. Exp. Allergy 35, 914–919.

    Article  CAS  PubMed  Google Scholar 

  • de Vries J. E. 1995 Immunosuppresive and anti-inflammatory properties of interleukin-10. Ann. Med. 27, 537–541.

    Article  CAS  PubMed  Google Scholar 

  • Ferlay J., Shin H. R., Bray F., Forman D., Mathers C. and Parkin D. M. 2010 Cancer incidence and mortality worldwide. International Agency for Research on Cancer GLOBOCAN 2008 (http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900).

  • Fortis C., Foppoli M., Gianotti L., Galli L., Citterio G., Consogno G., Gentilini O. and Braga M. 1996 Increased interleukin-10 serum levels in patients with solid tumors. Cancer Lett. 104, 1–5.

    Article  CAS  PubMed  Google Scholar 

  • Fujieda S., Sunaga H., Tsuzuki H., Fank G. K. and Saito H. 1999 IL 10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Lett. 136, 1–9.

    Article  CAS  PubMed  Google Scholar 

  • Guo W., Wang N., Wang Y. M., Li Y., Wen D. G., Chen Z. F. et al. 2005 Interleukin-10 –1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. World J. Gastroenterol. 11, 858–862.

    CAS  Google Scholar 

  • Hatanaka H., Abe Y., Naruke M., Tokunaga T., Oshika Y., Kawakami T. et al. 2001 Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in nonsmall cell lung cancer. Clin. Cancer Res. 7, 1287–1292.

    CAS  PubMed  Google Scholar 

  • Howell W. M., Turner S. J., Bateman A. C. and Theaker J. M. 2001 IL 10 promoter polymorphisms influence tumor development in cutaneous Malignant melanoma. Genes Immun. 2, 25–31.

    Article  CAS  PubMed  Google Scholar 

  • Jablonska E., Piotrowski L. and Grabowska Z. 1997 Serum levels of IL-1b, IL-6, TNF α, sTNF-RI and CRP in patients with oral cavity cancer. Pathol. Oncol. Res. 3, 126–129.

    Article  PubMed  Google Scholar 

  • Karcher J., Reisser C., Daniel V. and Herold-Mende C. 1999 Cytokine expression of transforming growth factor-beta 2 and interleukin-10 in squamous cell carcinomas of the head and neck: comparison of tissue expression and serum levels. HNO 47, 879–884.

    Article  CAS  PubMed  Google Scholar 

  • Lin M. T., Storer B., Martin P. J., Tseng L. H., Gooley T., Chen P. J. and Hansen J. A. 2003 Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplanation. N. Engl. J. Med. 349, 2201–2210.

    Article  CAS  PubMed  Google Scholar 

  • Manoochehr R., Simin K. and Maryam B. 2008 Interleukin-10 gene polymorphisms and susceptibility to brucellosis in Iranian patients. Iran. J. Immunol. 5, 131–135.

    Google Scholar 

  • Massano J., Regateiro F. S., Januario G. and Ferreira A. 2006 Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102, 67–76.

    Article  PubMed  Google Scholar 

  • McCarron S. L., Edwards S., Evans P. R., Gibbs R., Dearnaley D. P., Dowe A. et al. 2002 Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 62, 3369–3372.

    CAS  PubMed  Google Scholar 

  • McDowell J. D. 2006 An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol. Clin. North. Am. 39, 277–294.

    Article  PubMed  Google Scholar 

  • Meenagh A., Williams F., Ross O. A., Patterson C., Gorodezky C., Hammond M. et al. 2002 Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the middle East and south America. Hum. Immunol. 63, 1055– 1061.

    Article  CAS  PubMed  Google Scholar 

  • Nagata J., Kijima H., Hatanaka H., Tokunaga T., Takagi A., Mine T. et al. 2002 Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer. Int. J. Mol. Med. 10, 169–172.

    CAS  PubMed  Google Scholar 

  • Neville B. W. and Day T. A. 2002 Oral cancer and precancerous lesions. CA Cancer J. Clin. 52, 195–215.

    Article  PubMed  Google Scholar 

  • Palli D., Saieva C., Luzzi I., Masala G., Topa S., Sera F. et al. 2005 Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am. J. Gastroenterol. 100, 1941–1948.

    Article  CAS  PubMed  Google Scholar 

  • Petersen P. E. 2005 Strengthening the prevention of oral cancer: the WHO perspective. Commun. Dent. Oral. Epidemiol. 33, 397–399.

    Article  Google Scholar 

  • Raeiszadeh J. S., Mahesh P. A., Jayaraj B. S., Holla A. D., Vishweswaraiah S. and Ramachandra N. B. 2015 IL 10 and IL17F promoter single nucleotide polymorphism and asthma: a case–control study in south India. Lung Jun. 25 (In press).

  • Rasmussen S. K., Urhammer S. A., Jensen J. N., Hansen T., Borch-Johnsen K. and Pedersen O. 2000 The –238 and –308 G →A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J. Clin. Endocrinol. Metab. 85, 1731–1734.

    CAS  PubMed  Google Scholar 

  • Rhodus N. L., Ho V., Miller C. S., Myers S. and Ondrey F. 2005 NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect. Prev. 29, 42–45.

    Article  CAS  PubMed  Google Scholar 

  • Savage S. A., Abnet C. C., Haque K., Mark S. D., Qiao Y. L., Dong Z. W. et al. 2004 Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high risk chinese population. Cancer Epidemiol. Biomarkers Prev. 13, 1547–1549.

    CAS  PubMed  Google Scholar 

  • Saxena M., Srivastava N. and Banerjee M. 2013 Association of IL-6, TNF- α and IL 10 gene polymorphisms with type 2 diabetes mellitus. Mol. Biol. Rep. 40, 6271–6279.

    Article  CAS  PubMed  Google Scholar 

  • Seifart C., Plagens A., Dempfle A., Clostermann U., Vogelmeier C., von Wichert P. and Seifart U. 2005 TNF-alpha, TNF-beta, IL -6, and IL 10 polymorphisms in patients with lung cancer. Dis. Markers 21, 157–165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Srivastava M., Ranjan A., Choudhary J. K., Tripathi M. K., Verma S., Dixit V. K. et al. 2014 Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenario. J. Interferon Cytokine Res. 34, 547–551.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • St John M. A., Li Y., Zhou X., Denny P., Ho C. M., Montemagno C. et al. 2004 Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 130, 929–935.

    Article  PubMed  Google Scholar 

  • Trabace S., Brioli G., Lulli P., Morellini M., Giacovazzo M., Cicciarelli G. and Martelletti P. 2002 Tumor necrosis factor gene polymorphism in migraine. Headache 42, 341–345.

    Article  PubMed  Google Scholar 

  • Tsai M. H., Chen W. C., Tsai C. H., Hang L. W. and Tsai F. J. 2005 Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J. Clin. Lab. Anal. 19, 93–98.

    Article  CAS  PubMed  Google Scholar 

  • Vairaktaris E., Yapijakis C., Wiltfang J., Ries J., Vylliotis A., Derka S., Vasiliou S. and Neukam F. W. 2005 Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res. 25, 2561–2565.

    CAS  PubMed  Google Scholar 

  • Vairaktaris E., Yapijakis C., Serefoglou Z., Derka S., Vassiliou S., Nkenke E. et al. 2007a The interleukin-8 (–251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur. J. Surg. Oncol. 33, 504–507.

    Article  CAS  PubMed  Google Scholar 

  • Vairaktaris E., Yannopoulos A., Vassiliou S., Serefoglou Z., Vylliotis A., Nkenke E. et al. 2007b Strong association of interleukin-4 (–590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans. Oral. Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 104, 796– 802.

    Article  PubMed  Google Scholar 

  • Vairaktaris E., Serefoglou Z., Yapijakis C., Stathopoulos P., Vassiliou, S., Derka S. et al. 2007c The interleukin-1 beta gene polymorphism + 3953 C/T is not associated with risk for oral . Anticancer Res. 27, 3981–3986.

    CAS  PubMed  Google Scholar 

  • Vairaktaris E., Yapijakis C., Tsigris C., Vassiliou S., Derka S., Nkenke E. et al. 2007d Association of angiotensin converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol. 46, 1097–1102.

    Article  CAS  PubMed  Google Scholar 

  • Vairaktaris E., Yapijakis C., Serefoglou Z., Derka S., Vassiliou S., Nkenke E. et al. 2008 The interleukin-10 (−1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. Anticancer Res. 28, 309– 314.

    CAS  PubMed  Google Scholar 

  • Williams H. K. 2000 Molecular pathogenesis of oral squamous carcinoma. Mol. Pathol. 53, 165–172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xu J., Lowey J., Wiklund F., Sun J., Londmark F., Hsu F. C. et al. 2005 The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 14, 2563–2568.

    Article  CAS  Google Scholar 

  • Yapijakis C., Serefoglou Z., Vylliotis A., Nkenke E., Derka S., Vassiliou S. et al. 2009 Association of polymorphisms in tumor necrosis factor alpha and beta genes with increased risk for oral cancer. Anticancer Res. 29, 2379–2386.

    CAS  PubMed  Google Scholar 

  • Yilmaz V., Yentur S. P. and Saruhan-Direskeneli G. 2005 IL -12 and IL 10 polymorphisms and their effects on cytokine production. Cytokine 30, 188–194.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by Department of Biochemistry, King George’s Medical University, Lucknow, Uttar Pradesh, India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to SHALINI GUPTA.

Additional information

[Hussain S. R., Ahmad M. K., Mahdi A. A., Naqvi H., Ahmad M. W., Srivastava S., Nigam K. and Gupta S. 2016 Association of interleukin-10 (A1082G) gene polymorphism with oral squamous cell carcinoma in north Indian population. J. Genet. 95, xx–xx]

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HUSSAIN, S.R., AHMAD, M.K., MAHDI, A.A. et al. Association of interleukin-10 (A1082G) gene polymorphism with oral squamous cell carcinoma in north Indian population. J Genet 95, 249–255 (2016). https://doi.org/10.1007/s12041-016-0626-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-016-0626-1

Keywords

Navigation